ABSTRACT
Herein, a CuNiFe LDHs/BiO2-x composite photocatalyst was successfully synthesized using a hydrothermal method and applied to activate peroxymonosulfate to degrade ciprofloxacin under visible light irradiation. Owing to the synergistic effect of photocatalysis and PMS activation, a high removal efficiency of CIP up to 88.3% was achieved. The prepared photocatalysts were characterized using XRD, FT-IR, SEM, XPS, UV-Vis DRS, and other methods. The optimal loading amount of CuNiFe LDHs was determined, and the effects of PMS dosage, initial pH value, and inorganic anions (Cl-, CO32-, and NO3-) on the degradation were investigated. Electron paramagnetic resonance and free radical trapping experiments demonstrated that·OH and h+ were the main active species for degrading CIP, and the possible degradation mechanism of the system was proposed.
ABSTRACT
In the title compound, [Fe(L)2Cl(H2O)]·0.5CH3CN, (HL is 3-eth-oxy-2-hy-droxy-benzaldehyde, C9H10O3), there are two independent complex mol-ecules and one aceto-nitrile solvent mol-ecule in the asymmetric unit. In each complex mol-ecule, the Fe(III) ion has a distorted O5Cl octa-hedral coordination environment defined by two bidentate 2-eth-oxy-6-formyl-phenolato ligands, one Cl atom and one water mol-ecule. In the crystal, O-Hâ¯O hydrogen bonds link the two independent mol-ecules to form a dimer. The solvent mol-ecule is linked to the complex mol-ecule by a weak C-Hâ¯O hydrogen bond. Further weak C-Hâ¯O inter-actions along with weak C-Hâ¯Cl hydrogen bonds link the components into chains parallel to [001].
ABSTRACT
In the title compound, [Co(C8H7BrNO)3], the Co(III) ion is coordinated in a slightly distorted octa-hedral environment by three N atoms and three O atoms from three bidentate 4-bromo-2-(methyl-imino-meth-yl)phenolate ligands. The dihedral angles between the benzene rings are 82.6â (2), 57.1â (2) and 62.9â (2)°. In the crystal, mol-ecules are linked by pairs of weak C-Hâ¯Br hydrogen bonds, forming inversion dimers.
ABSTRACT
Berberine (BBR) is one of the main constituents in Rhizoma coptidis and it has widely been used for the treatment of diabetic nephropathy. The aims of the study were to investigate the effects and mechanism of action of berberine on renal damage in diabetic rats. Diabetes and hyperglycaemia were induced in rats by a high-fat diet and intraperitoneal injection of 40 mg/kg streptozotocin (STZ). Rats were randomly divided into 5 groups, such as i) control rats, ii) untreated diabetic rats iii) 250 mg/kg metformin-treated, iv and v) 100 and 200 mg/kg berberine-treated diabetic rats and treated separately for 8 weeks. The fasting blood glucose, insulin, total cholesterol, triglyceride, glycosylated hemoglobin were measured in rats. Kidneys were isolated at the end of the treatment for histology, Western blot analysis and estimation of malonaldehyde (MDA), superoxide dismutase (SOD) and renal advanced glycation endproducts (AGEs). The results revealed that berberine significantly decreased fasting blood glucose, insulin levels, total cholesterol, triglyceride levels, urinary protein excretion, serum creatinine (Scr) and blood urea nitrogen (BUN) in diabetic rats. The histological examinations revealed amelioration of diabetes-induced glomerular pathological changes following treatment with berberine. In addition, the protein expressions of nephrin and podocin were significantly increased. It seems likely that in rats berberine exerts an ameliorative effect on renal damage in diabetes induced by high-fat diet and streptozotocin. The possible mechanisms for the renoprotective effects of berberine may be related to inhibition of glycosylation and improvement of antioxidation that in turn upregulate the expressions of renal nephrin and podocin.
